8-K//Current report
Acrivon Therapeutics, Inc. 8-K
Accession 0000950170-25-086246
$ACRVCIK 0001781174operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:28 PM ET
Size
174.4 KB
Accession
0000950170-25-086246
Documents
- 8-Kacrv-20250613.htmPrimary
8-K
- EX-101.SCHacrv-20250613.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-086246-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLacrv-20250613_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeoperating
Related Parties
1- filerCIK 0001781174
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:28 PM ET
- Size
- 174.4 KB